• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2011 年中国北京猩红热流行期间 A 组链球菌流行株的特征。

Characteristics of group A Streptococcus strains circulating during scarlet fever epidemic, Beijing, China, 2011.

机构信息

Beijing Center for Disease Prevention and Control, School of Public Health and Family Medicine, Capital Medical University, Beijing, China.

出版信息

Emerg Infect Dis. 2013 Jun;19(6):909-15. doi: 10.3201/eid1906.121020.

DOI:10.3201/eid1906.121020
PMID:23735582
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4816378/
Abstract

Scarlet fever is one of a variety of diseases caused by group A Streptococcus (GAS). During 2011, a scarlet fever epidemic characterized by peak monthly incidence rates 2.9-6.7 times higher than those in 2006-2010 occurred in Beijing, China. During the epidemic, hospital-based enhanced surveillance for scarlet fever and pharyngitis was conducted to determine characteristics of circulating GAS strains. The surveillance identified 3,359 clinical cases of scarlet fever or pharyngitis. GAS was isolated from 647 of the patients; 76.4% of the strains were type emm12, and 17.1% were emm1. Almost all isolates harbored superantigens speC and ssa. All isolates were susceptible to penicillin, and resistance rates were 96.1% to erythromycin, 93.7% to tetracycline, and 79.4% to clindamycin. Because emm12 type GAS is not the predominant type in other countries, wider surveillance for the possible spread of emm12 type GAS from China to other countries is warranted.

摘要

猩红热是由 A 组链球菌(GAS)引起的多种疾病之一。2011 年,中国北京发生了一场猩红热疫情,其月度发病率峰值是 2006-2010 年的 2.9-6.7 倍。在疫情期间,开展了基于医院的猩红热和咽炎强化监测,以确定循环 GAS 菌株的特征。监测确定了 3359 例猩红热或咽炎临床病例。从 647 名患者中分离出 GAS;76.4%的菌株为 emm12 型,17.1%为 emm1 型。几乎所有分离株都携带超抗原 speC 和 ssa。所有分离株均对青霉素敏感,对红霉素的耐药率为 96.1%,对四环素的耐药率为 93.7%,对克林霉素的耐药率为 79.4%。由于 emm12 型 GAS 不是其他国家的主要类型,因此有必要更广泛地监测 emm12 型 GAS 从中国传播到其他国家的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dda/4816378/9a20055ae51a/12-1020-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dda/4816378/9a20055ae51a/12-1020-F.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4dda/4816378/9a20055ae51a/12-1020-F.jpg

相似文献

1
Characteristics of group A Streptococcus strains circulating during scarlet fever epidemic, Beijing, China, 2011.2011 年中国北京猩红热流行期间 A 组链球菌流行株的特征。
Emerg Infect Dis. 2013 Jun;19(6):909-15. doi: 10.3201/eid1906.121020.
2
[Etiological characteristics of pyogenes isolated from children with scarlet fever in Tianjin from 2012 to 2016].[2012年至2016年天津猩红热患儿分离出的化脓菌的病原学特征]
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Oct 6;52(10):1045-1049. doi: 10.3760/cma.j.issn.0253-9624.2018.10.015.
3
Molecular epidemiology and antimicrobial resistance of group a streptococcus recovered from patients in Beijing, China.中国北京地区患者分离的 A 组链球菌的分子流行病学和抗菌药物耐药性研究。
BMC Infect Dis. 2020 Jul 13;20(1):507. doi: 10.1186/s12879-020-05241-x.
4
Epidemiological analysis of Group A Streptococcus infections in a hospital in Beijing, China.中国北京一家医院 A 组链球菌感染的流行病学分析。
Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2361-2371. doi: 10.1007/s10096-020-03987-5. Epub 2020 Jul 16.
5
Outbreak of scarlet fever associated with emm12 type group A Streptococcus in 2011 in Shanghai, China.2011 年中国上海爆发与emm12 型 A 组链球菌相关的猩红热疫情。
Pediatr Infect Dis J. 2012 Sep;31(9):e158-62. doi: 10.1097/INF.0b013e31825874f3.
6
Molecular epidemiological characteristics of Streptococcus pyogenes strains involved in an outbreak of scarlet fever in China, 2011.2011 年中国猩红热爆发中涉及的化脓性链球菌菌株的分子流行病学特征。
Biomed Environ Sci. 2013 Nov;26(11):877-85. doi: 10.3967/bes2013.016.
7
Increase of emm1 isolates among group A Streptococcus strains causing scarlet fever in Shanghai, China.中国上海猩红热致 A 组链球菌中emm1 分离株的增加。
Int J Infect Dis. 2020 Sep;98:305-314. doi: 10.1016/j.ijid.2020.06.053. Epub 2020 Jun 17.
8
[emm types of mutation in scarlet-fever-related group A streptococcal, among children in Beijing, 2011-2014].[2011 - 2014年北京儿童猩红热相关A组链球菌的emm基因突变类型]
Zhonghua Liu Xing Bing Xue Za Zhi. 2015 Dec;36(12):1397-400.
9
Prevalence and identification of antibiotic-resistant scarlet fever group A Streptococcus strains in some paediatric cases at Shenzhen, China.中国深圳部分儿科病例中抗药性猩红热 A 组链球菌菌株的流行情况和鉴定。
J Glob Antimicrob Resist. 2022 Sep;30:199-204. doi: 10.1016/j.jgar.2022.05.012. Epub 2022 May 23.
10
[Study on the super-antigen genes of group A strains isolated from patients with scarlet fever and pharyngeal infection, in Beijing, 2015-2017].[2015 - 2017年北京猩红热和咽感染患者分离出的A组菌株超抗原基因研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Oct 10;39(10):1375-1380. doi: 10.3760/cma.j.issn.0254-6450.2018.10.016.

引用本文的文献

1
Ongoing epidemic of scarlet fever in Shanghai and the emergence of M1 lineage group A : a 14-year surveillance study across the COVID-19 pandemic period.上海猩红热的持续流行及A群M1型菌株的出现:一项跨越新冠疫情时期的14年监测研究
Lancet Reg Health West Pac. 2025 May 13;58:101576. doi: 10.1016/j.lanwpc.2025.101576. eCollection 2025 May.
2
Clinical Snapshot of Group A Streptococcal Isolates from an Australian Tertiary Hospital.澳大利亚一家三级医院A组链球菌分离株的临床概况
Pathogens. 2024 Nov 1;13(11):956. doi: 10.3390/pathogens13110956.
3
The intricate pathogenicity of Group A : A comprehensive update.

本文引用的文献

1
Scarlet fever epidemic, Hong Kong, 2011.2011 年香港猩红热疫情。
Emerg Infect Dis. 2012 Oct;18(10):1658-61. doi: 10.3201/eid1810.111900.
2
Molecular characterization of the 2011 Hong Kong scarlet fever outbreak.2011 年香港猩红热爆发的分子特征。
J Infect Dis. 2012 Aug 1;206(3):341-51. doi: 10.1093/infdis/jis362. Epub 2012 May 21.
3
Outbreak of scarlet fever associated with emm12 type group A Streptococcus in 2011 in Shanghai, China.2011 年中国上海爆发与emm12 型 A 组链球菌相关的猩红热疫情。
A 组链球菌的复杂致病机制:全面更新。
Virulence. 2024 Dec;15(1):2412745. doi: 10.1080/21505594.2024.2412745. Epub 2024 Nov 5.
4
type distribution of group A in China during 1990 and 2020: a systematic review and implications for vaccine coverage.1990 年至 2020 年期间中国 A 群的型别分布:系统评价及对疫苗覆盖率的启示。
Front Public Health. 2023 May 30;11:1157289. doi: 10.3389/fpubh.2023.1157289. eCollection 2023.
5
Identification of epidemic scarlet fever group A strains in the paediatric population of Houston, TX, USA.美国德克萨斯州休斯顿市儿科人群中A组流行性猩红热菌株的鉴定。
Access Microbiol. 2021 Oct 26;3(10):000274. doi: 10.1099/acmi.0.000274. eCollection 2021.
6
A Review of : Public Health Risk Factors, Prevention and Control.《公共卫生风险因素、预防与控制综述》
Pathogens. 2021 Feb 22;10(2):248. doi: 10.3390/pathogens10020248.
7
Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes.噬菌体外毒素增强了引起猩红热的流行链球菌的定植适应性。
Nat Commun. 2020 Oct 6;11(1):5018. doi: 10.1038/s41467-020-18700-5.
8
Incidence of Scarlet Fever in Children in Jeju Province, Korea, 2002-2016: An Age-period-cohort Analysis.2002 - 2016年韩国济州岛儿童猩红热发病率:年龄-时期-队列分析
J Prev Med Public Health. 2019 May;52(3):188-194. doi: 10.3961/jpmph.18.299. Epub 2019 Apr 24.
9
Resurgence of scarlet fever in China: a 13-year population-based surveillance study.中国猩红热再现:一项基于人群的 13 年监测研究。
Lancet Infect Dis. 2018 Aug;18(8):903-912. doi: 10.1016/S1473-3099(18)30231-7. Epub 2018 May 29.
10
Defining Host Responses during Systemic Bacterial Infection through Construction of a Murine Organ Proteome Atlas.通过构建小鼠器官蛋白质组图谱来定义全身性细菌感染时的宿主反应。
Cell Syst. 2018 May 23;6(5):579-592.e4. doi: 10.1016/j.cels.2018.04.010. Epub 2018 May 16.
Pediatr Infect Dis J. 2012 Sep;31(9):e158-62. doi: 10.1097/INF.0b013e31825874f3.
4
Epidemiological and molecular characteristics of clinical isolates of Streptococcus pyogenes collected between 2005 and 2008 from Chinese children.2005 年至 2008 年间从中国儿童中采集的化脓性链球菌临床分离株的流行病学和分子特征。
J Med Microbiol. 2012 Jul;61(Pt 7):975-983. doi: 10.1099/jmm.0.042309-0. Epub 2012 Mar 22.
5
Group A Streptococcus emm gene types in pharyngeal isolates, Ontario, Canada, 2002-2010.2002-2010 年加拿大安大略省咽拭子分离的 A 组链球菌emm 基因型。
Emerg Infect Dis. 2011 Nov;17(11):2010-7. doi: 10.3201/eid1711.110159.
6
New 30-valent M protein-based vaccine evokes cross-opsonic antibodies against non-vaccine serotypes of group A streptococci.新型 30 价 M 蛋白疫苗引发针对 A 组链球菌非疫苗血清型的交叉调理抗体。
Vaccine. 2011 Oct 26;29(46):8175-8. doi: 10.1016/j.vaccine.2011.09.005. Epub 2011 Sep 13.
7
Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates.1998 年至 2009 年期间引起西班牙侵袭性疾病的酿脓链球菌分离株的流行病学和分子分析:与非侵袭性分离株的比较。
Eur J Clin Microbiol Infect Dis. 2011 Oct;30(10):1295-302. doi: 10.1007/s10096-011-1226-x. Epub 2011 Apr 15.
8
Streptococcus pyogenes isolates causing severe infections in Norway in 2006 to 2007: emm types, multilocus sequence types, and superantigen profiles.2006 年至 2007 年导致挪威严重感染的化脓性链球菌分离株:emm 型、多位点序列型和超抗原谱。
J Clin Microbiol. 2010 Mar;48(3):842-51. doi: 10.1128/JCM.01312-09. Epub 2009 Dec 30.
9
Global emm type distribution of group A streptococci: systematic review and implications for vaccine development.A群链球菌的全球emm型分布:系统评价及对疫苗研发的启示
Lancet Infect Dis. 2009 Oct;9(10):611-6. doi: 10.1016/S1473-3099(09)70178-1.
10
High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.中国从咽炎患儿中分离出的化脓性链球菌菌株对大环内酯类药物具有高耐药性。
Pediatr Pulmonol. 2009 May;44(5):436-41. doi: 10.1002/ppul.20976.